Search Results - "Evans, J.K."

Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind Phase III trial in patients undergoing open abdominal surgery by Diemunsch, P., Gan, T.J., Philip, B.K., Girao, M.J., Eberhart, L., Irwin, M.G., Pueyo, J., Chelly, J.E., Carides, A.D., Reiss, T., Evans, J.K., Lawson, F.C.

“…The neurokinin1 antagonist aprepitant is effective for prevention of chemotherapy-induced nausea and vomiting. We compared aprepitant with ondansetron for…”
Get full text

Effects of 6 months of moderate aerobic exercise training on immune function in the elderly by Woods, J.A, Ceddia, M.A, Wolters, B.W, Evans, J.K, Lu, Q, McAuley, E

“…The purpose of this study was to determine the effects of 6 months of moderate aerobic exercise on age-dysregulated measures of T lymphocyte and natural killer…”
Get full text

Association between Modifiable Risk Factors and Levels of Blood-Based Biomarkers of Alzheimer's and Related Dementias in the Look AHEAD Cohort by Hayden, K M, Mielke, M M, Evans, J K, Neiberg, R, Molina-Henry, D, Culkin, M, Marcovina, S, Johnson, K C, Carmichael, O T, Rapp, S R, Sachs, B C, Ding, J, Shappell, H, Wagenknecht, L, Luchsinger, J A, Espeland, M A

“…Emerging evidence suggests that a number of factors can influence blood-based biomarker levels for Alzheimer's disease (AD) and Alzheimer's related dementias…”
Get full text

Erratum to: Association between Modifiable Risk Factors and Levels of Blood-Based Biomarkers of Alzheimer's and Related Dementias in the Look AHEAD Cohort by Hayden, K M, Mielke, M M, Evans, J K, Neiberg, R, Molina-Henry, D, Culkin, M, Marcovina, S, Johnson, K C, Carmichael, O T, Rapp, S R, Sachs, B C, Ding, J, Shappell, H, Wagenknecht, L, Luchsinger, J A, Espeland, M A

“…[This corrects the article DOI: 10.14283/jarlife.2024.1.]…”
Get full text

The oral NK1 antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials by de Wit, R., Herrstedt, J., Rapoport, B., Carides, A.D., Guoguang-Ma, J., Elmer, M., Schmidt, C., Evans, J.K., Horgan, K.J.

“…In early clinical trials, the NK1 receptor antagonist, aprepitant (EMEND®) was shown to improve the protection provided by the best available therapy…”
Get full text

Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists by Hesketh, P.J., Van Belle, S., Aapro, M., Tattersall, F.D., Naylor, R.J., Hargreaves, R., Carides, A.D., Evans, J.K., Horgan, K.J.

“…Advances in antiemetic therapy for chemotherapy-induced emesis have resulted in improved protection against symptoms occurring within 24 h of chemotherapy…”
Get full text

Addition of the Oral NK1 Antagonist Aprepitant to Standard Antiemetics Provides Protection Against Nausea and Vomiting During Multiple Cycles of Cisplatin-Based Chemotherapy by DE WIT, R, HERRSTEDT, J, RAPOPORT, B, CARIDES, A. D, CARIDES, G, ELMER, M, SCHMIDT, C, EVANS, J. K, HORGAN, K. J

“…This analysis evaluated whether the antiemetic efficacy of the NK1 receptor antagonist aprepitant (EMEND trade mark, Merck, Whitehouse Station, NJ) plus…”
Get full text

Addition of the Oral NK 1 Antagonist Aprepitant to Standard Antiemetics Provides Protection Against Nausea and Vomiting During Multiple Cycles of Cisplatin-Based Chemotherapy by de Wit, R., Herrstedt, J., Rapoport, B., Carides, A.D., Carides, G., Elmer, M., Schmidt, C., Evans, J.K., Horgan, K.J.

“…Purpose: This analysis evaluated whether the antiemetic efficacy of the NK 1 receptor antagonist aprepitant (EMEND ™ , Merck, Whitehouse Station, NJ) plus…”
Get full text

The oral NK1 antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy by de Wit, R., Herrstedt, J., Rapoport, B., Carides, A.D., Guoguang-Ma, J., Elmer, M., Schmidt, C., Evans, J.K., Horgan, K.J.

Get full text

Aprepitant: an oral NK1 antagonist for the prevention of nausea and vomiting induced by highly emetogenic chemotherapy by Pendergrass, Kelly, Hargreaves, Richard, Petty, Kevin J, Carides, Alexandra D, Evans, Judith K, Horgan, Kevin J

“…This paper reviews the clinical profile of aprepitant, the first neurokinin-1 (NK(1)) receptor antagonist to be approved for use in the prevention of…”
Get full text

Integrating ‘Big’ geoscience data into the petascale national environmental research interoperability platform (NERDIP): Successes and unforeseen challenges by Wyborn, Lesley, Evans, Benjamin J. K.

“…The Australian Government has begun an initiative to organise publicly funded national data assets and make them accessible for research through the Research…”
Get full text

Smart Geodesic Tracing in GRworkbench by Evans, Benjamin J. K., Scott, Susan M., Searle, Antony C.

Get full text

The Exercise Capacity of Blind Children by Jankowski, L.W., Evans, J.K.

“…The aim of the study was to determine whether blind children in a well-equipped modern institution are receiving enough physical education activities to…”
Get full text